Significance of mutations in embB Codon 306 for prediction of ethambutol resistance in clinical Mycobacterium tuberculosis isolates

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 5, 2006, Pages 1900-1902

  Plinke, Claudia ^a   Rüsch Gerdes, Sabine ^a   Niemann, Stefan ^a  

^a RESEARCH CENTER BORSTEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CODON; CONTROLLED STUDY; DNA EXTRACTION; DNA FINGERPRINTING; EMBB GENE; GENE MUTATION; GENE SEQUENCE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ANTITUBERCULAR AGENTS; CODON; DRUG RESISTANCE, BACTERIAL; ETHAMBUTOL; GENES, BACTERIAL; HUMANS; MUTATION; MYCOBACTERIUM TUBERCULOSIS;

EID: 33646457033     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.50.5.1900-1902.2006     Document Type: Article

References (15)

1. Deutsches Institut für Normung. 1996. Empfindlichkeitsprüfung von Tuberkulosebakterien gegen Chemotherapeutika. Norm 58943-8. Beuth Verlag, Berlin, Germany.
2. Hazbón, M. H., M. Bobadilla del Valle, M. I. Guerrero, M. Varma-Basil, I. Filliol, M. Cavatore, R. Colangeli, H. Safi, H. Billman-Jacobe, C. Lavender, J. Fyfe, L. Garcia-Garcia, A. Davidow, M. Brimacombe, C. I. Leon, T. Porras, M. Bose, F. Chaves, K. D. Eisenach, J. Sifuentes-Osornio, A. Ponce de Leon, M. D. Cave, and D. Alland. 2005. Role of embB codon 306 mutations in Mycobacterium tuberculosis revisited: a novel association with broad drug resistance and IS6110 clustering rather than ethambutol resistance. Antimicrob. Agents Chemother. 49:3794-3802.
3. Isola, D., M. Pardini, F. Varaine, S. Niemann, S. Rüsch-Gerdes, L. Fattorini, G. Orefici, F. Meacci, C. Trappetti, M. R. Oggioni, the LONG-DRUG study group, and G. Orru. 2005. A pyrosequencing assay for rapid recognition of SNPs in Mycobacterium tuberculosis embB306 region. J. Microbiol. Methods 62:113-120.
4. Lee, A. S., S. N. Othman, Y. M. Ho, and S. Y. Wong. 2004. Novel mutations within the embB gene in ethambutol-susceptible clinical isolates of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 48:4447-4449.
5. Mokrousov, I., T. Otten, B. Vyshnevskiy, and O. Narvskaya. 2002. Detection of embB306 mutations in ethambutol-susceptible clinical isolates of Mycobacterium tuberculosis from northwestern Russia: implications for genotypic resistance testing. J. Clin. Microbiol. 40:3810-3813.
6. Niemann, S., and S. Rüsch-Gerdes. 2002. Therapy and drug resistance, p. 84-96. In S. H. E. Kaufmann and H. Hahn (ed.), Mycobacteria and TB, vol. 2. Karger, Basel, Switzerland.
7. Parsons, L. M., A. Somoskovi, R. Urbanczik, and M. Salfinger. 2004. Laboratory diagnostic aspects of drug resistant tuberculosis. Frontiers Biosci. 9:2086-2105.
8. Parsons, L. M., M. Salfinger, A. Clobridge, J. Dormandy, L. Mirabello, V. L. Polletta, A. Sanic, O. Sinyavskiy, S. C. Larsen, J. Driscoll, G. Zickas, and H. W. Taber. 2005. Phenotypic and molecular characterization of Mycobacterium tuberculosis isolates resistant to both isoniazid and ethambutol. Antimicrob. Agents Chemother. 49:2218-2225.
9. Ramaswamy, S. V., A. G. Amin, S. Goksel, C. E. Stager, S. J. Dou, H. El Sahly, S. L. Moghazeh, B. N. Kreiswirth, and J. M. Musser. 2000. Molecular genetic analysis of nucleotide polymorphisms associated with ethambutol resistance in human isolates of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 44:326-336.
10. Sreevatsan, S., K. E. Stockbauer, X. Pan, B. N. Kreiswirth, S. L. Moghazeh, W. R. Jacobs, Jr., A. Telenti, and J. M. Musser. 1997. Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations. Antimicrob. Agents Chemother. 41:1677-1681.
11. Tracevska, T., I. Jansone, A. Nodieva, O. Marga, G. Skenders, and V. Baumanis. 2004. Characterisation of rpsL, rrs and embB mutations associated with streptomycin and ethambutol resistance in Mycobacterium tuberculosis. Res. Microbiol. 155:830-834.
12. Van Embden, J. D. A., M. D. Cave, J. T. Crawford, J. W. Dale, K. D. Eisenach, B. Gicquel, P. Hermans, C. Martin, R. McAdam, T. M. Shinnick, and P. M. Small. 1993. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J. Clin. Microbiol. 31:406-409.
13. Van Rie, A., R. Warren, I. Mshanga, A. M. Jordaan, G. D. van der Spuy, M. Richardson, J. Simpson, R. P. Gie, D. A. Enarson, N. Beyers, P. D. van Helden, and T. C. Victor. 2001. Analysis for a limited number of gene codons can predict drug resistance of Mycobacterium tuberculosis in a high-incidence community. J. Clin. Microbiol. 39:636-641.
14. World Health Organization. 2004. Anti-tuberculosis drug resistance in the world: third global report. World Health Organization, Geneva, Switzerland.
15. Zhang, Y., and A. Telenti. 2000. Genetics of drug resistance in Mycobacterium tuberculosis, p. 235-251. In G. F. Harfull and W. R. Jacobs, Jr. (ed.), Molecular genetics of mycobacteria, ASM Press, Washington, D.C.